Why The Procter & Gamble Company (PG) stock moved
The Procter & Gamble Company (PG) shares climbed 5.6% to $165.59 as of October 23, 2026, a significant gain from the prior close of $156.84. BestStocks flagged the session as a major change for PG. Below, we break down what changed for PG, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
PG climbed 5.6% to $165.59
PG climbed 5.6% in its latest session, moving from $156.84 to $165.59.
What it means for The Procter & Gamble Company investors
For The Procter & Gamble Company investors, the balance of recent signals points to a strong bullish shift. On the constructive side: Earnings beat with positive market reaction; Strong 5.6% price move with conviction. Weighing against that: New SEC filing — review for material disclosures; New SEC filing — review for material disclosures. Wall Street's consensus price target sits at $160.22, implying -3.2% downside from $165.59. Over the past 90 days analysts logged 1 upgrade and 2 downgrades. BestStocks rates the overall signal quality medium (70/100). With earnings roughly 97 days out, the next report is the most likely near-term test of the move.
PG price reaction
PG last traded at $165.59, up $8.75 (+5.58%) from the previous close of $156.84. The session traded on 2.4× average volume (very high), so the move carried above-average conviction. Over the past month the stock has ranged between $143.95 and $165.59, and it currently sits about 100% of the way up that band.
Bullish and bearish analyst opinions on The Procter & Gamble Company (PG)
The consensus analyst price target on The Procter & Gamble Company (PG) is $160.22, 3.2% below the recent $165.59. Over the past 90 days analysts logged 1 upgrade, 5 maintains, and 2 downgrades. Here is how the bullish and bearish cases on PG line up.
The bullish case
- The Street's most bullish target is $172.00 (+3.9%).
- 1 analyst upgrade in the past 90 days, most recently Evercore ISI Group to Outperform (2026-10-06).
- Earnings beat with positive market reaction.
- Strong 5.6% price move with conviction.
- Volume 2.4x average — institutional conviction.
The bearish case
- The consensus analyst price target of $160.22 sits 3.2% below the recent $165.59, so the average target sees limited room to run.
- The most bearish analyst target is $149.00 (-10.0%).
- 2 analyst downgrades in the past 90 days, most recently Argus Research to Hold (2026-08-07).
Weighing both sides, BestStocks' composite read of recent signals is strongly bullish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Oct 23, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for PG
In-depth PG event analyses
Frequently asked questions about PG
Why did The Procter & Gamble Company (PG) stock move?
PG climbed 5.6% to $165.59. No single company-specific catalyst was confirmed during the move window, and it looks technical.
How much did PG stock rise?
PG gained 5.58% ($8.75) versus the prior close of $156.84, last trading at $165.59 on 2.4× average volume.
When is The Procter & Gamble Company's next earnings date?
PG's next earnings report is estimated for 2027-01-28 — about 97 days away.
What is the analyst price target for PG?
The consensus analyst price target for PG is $160.22, about 3.2% below the current $165.59. Over the past 90 days, analysts recorded 1 upgrade, 5 maintains, and 2 downgrades.
How BestStocks tracks PG
This page is generated automatically by BestStocks' change-detection system after its price and volume cleared PG-specific materiality thresholds, triggering an evidence check. It draws on 20 tracked change events for PG, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of October 23, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.